Gelteq Limited focuses on developing, testing, and commercializing white label gel-based delivery solutions for humans and animals in Asia-Pacific Region. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. The company has a strategic alliance with IDT Australia Limited for the development and scale up of its gel-based products across diverse global pharmaceutical, nutraceutical and animal health markets. Gelteq Limited was incorporated in 2017 and is headquartered in Caulfield, Australia.
Metrics to compare | GELS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGELSPeersSector | |
---|---|---|---|---|
P/E Ratio | −5.2x | −1.0x | −0.5x | |
PEG Ratio | - | 0.00 | 0.00 | |
Price/Book | 1.4x | 1.3x | 2.6x | |
Price / LTM Sales | 71.3x | 2.8x | 3.2x | |
Upside (Analyst Target) | - | 30.6% | 42.7% | |
Fair Value Upside | Unlock | 17.6% | 5.8% | Unlock |